Usana Health Sciences Inc (NYSE:USNA)
$ 27.54 +0.36 (+1.32%) Market Cap: 519.40 Mil Enterprise Value: 410.11 Mil PE Ratio: 15.13 PB Ratio: 0.98 GF Score: 65/100

Q1 2025 USANA Health Sciences Inc Earnings Call Transcript

Apr 23, 2025 / 03:00PM GMT
Release Date Price: $25.43 (+4.91%)

Key Points

Positve
  • Usana Health Sciences Inc (USNA) reported a 12% year-over-year growth in consolidated net sales in constant currency, aligning with internal expectations.
  • The company saw sequential growth in net sales and active customers in its largest market, mainland China, with increases of 6% and 4% respectively.
  • Usana Health Sciences Inc (USNA) successfully expanded its product offerings in several markets, including a new chewable calcium product for children in China.
  • The newly acquired Hiya business continues to deliver robust results with strong growth in net sales and active monthly subscribers.
  • The company has proactively built inventory to mitigate potential tariff impacts and is exploring alternate sourcing relationships to address emerging trade policies.
Negative
  • Consumer sentiment in key markets remains cautious, impacting overall business momentum.
  • The potential impact of tariffs and trade policies remains highly uncertain, posing a risk to future financial performance.
  • The India market is progressing slowly, with high expectations yet to be realized.
  • Usana Health Sciences Inc (USNA) faces competition from products with artificial ingredients, requiring differentiation through natural product offerings.
  • The integration of Hiya presents challenges in balancing synergy opportunities without overwhelming the existing team and strategy.
Operator

Greetings. Welcome to the USANA Health Sciences first quarter conference call. At this time, all participants are in a listen-only mode. (Operator Instructions)

Please note that this conference is being recorded. I will now turn the conference over to your host, Andrew Masuda, Director of Investor Relations. Thank you. You may begin.

Andrew Masuda
Usana Health Sciences Inc - Director of Investor Relations

Thank you, Diego, and good morning everyone. We appreciate you joining us to review our first quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.

As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot